DarioHealth (DRIO) Gross Profit (2014 - 2026)

DarioHealth (DRIO) has reported Gross Profit for 13 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit rose 7.69% year-over-year to $3.2 million; the trailing twelve-month figure through Jun 2026 stood at $12.2 million (down 18.18% YoY), and the FY2025 full-year result was $12.7 million, down 4.54% from the prior year.
• Gross Profit was little changed at $3.2 million in Q2 2026 per DRIO's latest filing, from $3.2 million in the prior quarter.
• Across five years, Gross Profit topped out at $4.2 million in Q4 2024 and bottomed at $132000.0 in Q4 2023.
• Historically, Gross Profit has averaged $2.7 million across 5 years, with a median of $2.9 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Gross Profit sank 95.17% in 2023, then soared 3083.33% in 2024.
• Over 5 years, Gross Profit stood at $2.7 million in 2022, then tumbled by 95.17% to $132000.0 in 2023, then jumped by 3083.33% to $4.2 million in 2024, then slumped by 33.27% to $2.8 million in 2025, then rose by 13.84% to $3.2 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $3.2 million, $3.2 million, and $2.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.